Author:
Barré Jean,Sabatier Jean-Marc,Annweiler Cédric
Subject
Pharmacology (medical),Pharmacology
Reference56 articles.
1. Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19);Ahn;J. Microbiol. Biotechnol.,2020
2. Cysteinyl leukotriene receptor antagonist montelukast ameliorates acute lung injury following haemorrhagic shock in rats;Al-Amran;Eur. J. Cardiothorac. Surg.,2013
3. Influence of Atherosclerosis on the Vascular Reactivity of Isolated Human Epicardial Coronary Arteries to Leukotriene C4;Allen;Cardioscience,1993
4. The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast;Almerie;Med. Hypotheses,2020
5. Montelukast, Leukotriene Inhibitor, Reduces LPS-Induced Acute Lung Inflammation and Human Neutrophil Activation;Aquino-Junior;Arch. Bronconeumol.,2019
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献